Company registration number 15244647 (England and Wales)
EMOTE CARE LTD
UNAUDITED FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 OCTOBER 2024
PAGES FOR FILING WITH REGISTRAR
EMOTE CARE LTD
CONTENTS
Page
Balance sheet
1
Statement of changes in equity
2
Notes to the financial statements
3 - 6
EMOTE CARE LTD
BALANCE SHEET
AS AT 31 OCTOBER 2024
31 October 2024
- 1 -
2024
Notes
£
£
Fixed assets
Intangible assets
4
514
Current assets
Debtors
5
102,888
Cash at bank and in hand
2,221
105,109
Creditors: amounts falling due within one year
6
(54,175)
Net current assets
50,934
Net assets
51,448
Capital and reserves
Called up share capital
7
121,402
Share premium account
41,381
Profit and loss reserves
(111,335)
Total equity
51,448

For the financial year ended 31 October 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

T he members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The directors of the company have elected not to include a copy of the profit and loss account within the financial statements.true

The financial statements were approved by the board of directors and authorised for issue on 24 October 2025 and are signed on its behalf by:
Mr J E Morse
Director
Company registration number 15244647 (England and Wales)
EMOTE CARE LTD
STATEMENT OF CHANGES IN EQUITY
FOR THE YEAR ENDED 31 OCTOBER 2024
- 2 -
Share capital
Share premium account
Profit and loss reserves
Total
Notes
£
£
£
£
Year ended 31 October 2024:
Loss and total comprehensive income
-
-
(111,335)
(111,335)
Issue of share capital
7
121,402
41,381
-
162,783
Balance at 31 October 2024
121,402
41,381
(111,335)
51,448
EMOTE CARE LTD
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 OCTOBER 2024
- 3 -
1
Accounting policies
Company information

Emote Care Ltd is a private company limited by shares incorporated in England and Wales. The registered office is 86-90 Paul Street, 3rd Floor, London, EC2A 4NE.

1.1
Accounting convention

These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The financial statements are prepared in sterling, which is the functional currency of the company. Monetary a mounts in these financial statements are rounded to the nearest £.

The financial statements have been prepared under the historical cost convention, [modified to include the revaluation of freehold properties and to include investment properties and certain financial instruments at fair value]. The principal accounting policies adopted are set out below.

1.2
Research and development expenditure

Research and development expenditure is written off against profits in the year in which it is incurred.

1.3
Intangible fixed assets other than goodwill

Intangible assets acquired separately from a business are recognised at cost and are subsequently measured at cost less accumulated amortisation and accumulated impairment losses.

Amortisation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:

Patents & licences
3 years straight line
1.4
Impairment of fixed assets

At each reporting period end date, the company reviews the carrying amounts of its tangible and intangible assets to determine whether there is any indication that those assets have suffered an impairment loss. If any such indication exists, the recoverable amount of the asset is estimated in order to determine the extent of the impairment loss (if any). Where it is not possible to estimate the recoverable amount of an individual asset, the company estimates the recoverable amount of the cash-generating unit to which the asset belongs.

Recognised impairment losses are reversed if, and only if, the reasons for the impairment loss have ceased to apply. Where an impairment loss subsequently reverses, the carrying amount of the asset (or cash-generating unit) is increased to the revised estimate of its recoverable amount, but so that the increased carrying amount does not exceed the carrying amount that would have been determined had no impairment loss been recognised for the asset (or cash-generating unit) in prior years. A reversal of an impairment loss is recognised immediately in profit or loss, unless the relevant asset is carried at a revalued amount, in which case the reversal of the impairment loss is treated as a revaluation increase.

1.5
Cash and cash equivalents

Cash and cash equivalents are basic financial assets and include cash at bank only.

EMOTE CARE LTD
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 OCTOBER 2024
1
Accounting policies
(Continued)
- 4 -
1.6
Financial instruments

The company has elected to apply the provisions of Section 11 ‘Basic Financial Instruments’ and Section 12 ‘Other Financial Instruments Issues’ of FRS 102 to all of its financial instruments.

Financial instruments are recognised in the company's balance sheet when the company becomes party to the contractual provisions of the instrument.

Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.

Basic financial assets

Basic financial assets, which include cash and bank balances, and other debtors are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest method unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Financial assets classified as receivable within one year are not amortised.

Classification of financial liabilities

Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities.

Basic financial liabilities

Basic financial liabilities, including trade creditors, and other creditors are initially recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future paymen ts discounted at a market rate of interest. Financial liabilities classified as payable within one year are not amortised.

Debt instruments are subsequently carried at amortised cost, using the effective interest rate method.

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. A m ounts payable are classified as current liabilities if payment is due within one year or less. If not, they are presented as non-current liabilities. Trade creditors are recognised initially at transaction price and subsequently measured at amortised cost using the effective interest method.

1.7
Equity instruments

Equity instruments issued by the company are recorded at the proceeds received, net of transaction costs.

1.8
Employee benefits

The costs of short-term employee benefits are recognised as a liability and an expense.

2
Judgements and key sources of estimation uncertainty

In the application of the company’s accounting policies, the directors are required to make judgements, estimates and assumptions about the carrying amount of assets and liabilities that are not readily apparent from other sources. The estimates and associated assumptions are based on historical experience and other factors that are considered to be relevant. Actual results may differ from these estimates.

The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognised in the period in which the estimate is revised where the revision affects only that period, or in the period of the revision and future periods where the revision affects both current and future periods.

EMOTE CARE LTD
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 OCTOBER 2024
- 5 -
3
Employees

The average monthly number of persons (including directors) employed by the company during the year was:

2024
Number
Total
0
4
Intangible fixed assets
Patents & licences
£
Cost
At 29 October 2023
-
0
Additions
514
At 31 October 2024
514
Amortisation and impairment
At 29 October 2023 and 31 October 2024
-
0
Carrying amount
At 31 October 2024
514
5
Debtors
2024
Amounts falling due within one year:
£
Other debtors
102,888
6
Creditors: amounts falling due within one year
2024
£
Trade creditors
3,718
Other creditors
50,457
54,175
7
Called up share capital
2024
2024
Ordinary share capital
Number
£
Issued and not fully paid
Ordinary of 1p each
12,140,144
121,402
EMOTE CARE LTD
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 OCTOBER 2024
7
Called up share capital
(Continued)
- 6 -

On incorporation 10,000,000 Ordinary 1p shares were issued for a total consideration of £100,000. These remain unpaid as at the period end.

During the period, 2,140,144 Ordinary 1p shares were issued for a total consideration of £62,783. A balance of £41,972 remains unpaid as at the period end.

8
Events after the reporting date

On 24th March 2025, 520,485 Ordinary 1p shares were issued for a total consideration of £514,500.

On 22nd September 2025, a special resolution was passed for the share capital of the Company to be reduced by cancelling and extinguishing capital to the extent of 0.999p on each fully paid up Ordinary share of 1p each in the Company and reducing the nominal value of each issues fully paid up Ordinary share from 1p to 0.001p.

9
Related party transactions

Included in the accounts are amounts due to related parties totalling £48,770.

2024-10-31 2023-10-29 false false false 24 October 2025 CCH Software CCH Accounts Production 2025.300 No description of principal activity Mr J E Morse Mr B J Woodford 15244647 2023-10-29 2024-10-31 15244647 2024-10-31 15244647 core:PatentsTrademarksLicencesConcessionsSimilar 2024-10-31 15244647 core:WithinOneYear 2024-10-31 15244647 core:CurrentFinancialInstruments 2024-10-31 15244647 core:ShareCapital 2024-10-31 15244647 core:SharePremium 2024-10-31 15244647 core:RetainedEarningsAccumulatedLosses 2024-10-31 15244647 core:ShareCapitalOrdinaryShareClass1 2024-10-31 15244647 bus:Director1 2023-10-29 2024-10-31 15244647 core:RetainedEarningsAccumulatedLosses 2023-10-29 2024-10-31 15244647 core:ShareCapital 2023-10-29 2024-10-31 15244647 core:SharePremium 2023-10-29 2024-10-31 15244647 core:IntangibleAssetsOtherThanGoodwill 2023-10-29 2024-10-31 15244647 core:PatentsTrademarksLicencesConcessionsSimilar 2023-10-29 2024-10-31 15244647 core:PatentsTrademarksLicencesConcessionsSimilar 2023-10-28 15244647 core:PatentsTrademarksLicencesConcessionsSimilar core:ExternallyAcquiredIntangibleAssets 2023-10-29 2024-10-31 15244647 core:CurrentFinancialInstruments core:WithinOneYear 2024-10-31 15244647 bus:OrdinaryShareClass1 2023-10-29 2024-10-31 15244647 bus:OrdinaryShareClass1 2024-10-31 15244647 bus:PrivateLimitedCompanyLtd 2023-10-29 2024-10-31 15244647 bus:SmallCompaniesRegimeForAccounts 2023-10-29 2024-10-31 15244647 bus:FRS102 2023-10-29 2024-10-31 15244647 bus:AuditExemptWithAccountantsReport 2023-10-29 2024-10-31 15244647 bus:Director2 2023-10-29 2024-10-31 15244647 bus:FullAccounts 2023-10-29 2024-10-31 xbrli:pure xbrli:shares iso4217:GBP